Saama was founded by Suresh Katta in 2015.

Who are Saama's investors?

Saama's investors include Carrick Capital Partners, Intermountain Health, McKesson Ventures, Merck Global Health Innovation Fund, MSD Global Health Innovation Fund, Pfizer Venture Investments.

How much funding has Saama raised?

Saama has disclosed $35.8M raised across 1 round.

Where is Saama headquartered?

Saama is headquartered in Campbell, US.

Saama

Campbell, US · Founded 2015 · 6 known investors

Find your way into Saama

Paths you didn't know you had: your email and LinkedIn already hold routes to the Saama team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Saama provides AI-based data analytics solutions and services for the life sciences industry, with a focus on accelerating clinical trials. Its offerings also extend to sectors including banking and capital markets, consumer goods, insurance, and the public sector.

AI & Machine Learning Data & Infrastructure Digital Health Healthtech SaaS

Founders & leadership

Saama was founded in 2015 by Suresh Katta.

Suresh Katta Founder · Chairman EmeritusSuresh Katta founded Saama Technologies, an AI-driven clinical analytics platform company that has worked with major pharmaceutical firms including Pfizer, Merck, and Amgen; the company received a $430 million growth investment from Carlyle and a consortium of life science companies in 2021. He has spent over 25 years in technology and has been involved in philanthropic efforts including educational sponsorships and community development projects in India.

Simon Ho Chief Financial Officer2014–2019Simon Ho is an executive officer at Saama with over 25 years of experience in high-tech companies, including roles in venture-backed startups, mid-market firms, and large enterprises. He has led fundraising initiatives, M&A activities, and international operations across Asia, and brings expertise in SaaS business models and financial processes.

Board

Marc McMorris Board Member2015–2021Managing Director at Carrick Capital Partners

Ken ColemanBoard director

Dan FishbackBoard director

William BinchBoard director

Dan FairfaxBoard director

Stan MeresmanBoard director

Investors · 6

Carrick Capital Partnerslisted by Carrick Capital PartnersSan Franciscovia Marc McMorris · board

How we know: Carrick Capital Partners's portfolio page · board seat on SEC Form D · Not right? Tell us

Intermountain Healthlisted by Intermountain Health

McKesson Ventureslisted by McKesson VenturesSan Francisco

How we know: McKesson Ventures's portfolio page · Not right? Tell us

Merck Global Health Innovation Fundlisted by Merck Global Health Innovation FundRahway · $10M

How we know: Merck Global Health Innovation Fund's portfolio page · Not right? Tell us

MSD Global Health Innovation Fundlisted by MSD Global Health Innovation FundRahway · $2M – $10M

How we know: MSD Global Health Innovation Fund's portfolio page · Not right? Tell us

Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M

How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$35.8M disclosed across 1 round · 2015

▶$35.8MraisedJun 2015 · 5 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Ken ColemanDirector
Suresh KattaExecutive Officer, Director
Simon HoExecutive Officer
Dan FishbackDirector
William BinchDirector
Marc McMorrisDirector
Dan FairfaxDirector
Stan MeresmanDirector

Offering amount: $35.8M
Amount sold: $35.8M
First sale: May 2015
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Saama went on to found or lead other companies.

Nick MarkInvestor and AdvisorFounded Culmination Bio Anand Kumaresh TharmaratnamAdvisor to SaamaFounded Novotech

Related companies · 3

OpenAIOpenAI is an AI research and deployment company focused on developing artificial general intelligence (AGI) with emphasis on safety and beneficial outcomes for humanity.

CytelCytel provides software and biometrics solutions for clinical trial design and delivery in the life sciences industry. The company serves pharmaceutical companies sponsoring clinical trials and their biometrics and biostatistics teams.

SnowflakeSnowflake is a fully managed cloud data platform that integrates data ingestion, processing, analysis, and AI application development across multiple cloud providers. It serves enterprise customers with unified security, governance, and infrastructure for building data and AI workloads.

Companies working in the same space as Saama.

Frequently asked questions

What does Saama do?: Saama provides AI-based data analytics solutions and services for the life sciences industry, with a focus on accelerating clinical trials. Its offerings also extend to sectors including banking and capital markets, consumer goods, insurance, and the public sector.
Who founded Saama?: Saama was founded by Suresh Katta in 2015.
Who are Saama's investors?: Saama's investors include Carrick Capital Partners, Intermountain Health, McKesson Ventures, Merck Global Health Innovation Fund, MSD Global Health Innovation Fund, Pfizer Venture Investments.
How much funding has Saama raised?: Saama has disclosed $35.8M raised across 1 round.
Where is Saama headquartered?: Saama is headquartered in Campbell, US.